SynthesisFrontiers in human neuroscience2020
Employment and Work Ability of Persons With Brain Tumors: A Systematic Review.
Synthesis in Frontiers in human neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 26 citations in OpenAlex.
- Return to work and factors influencing recovery after endoscopic transsphenoidal surgery for hypothalamic and pituitary tumors.Scientific reports · 2025Article
- Symptom distress and treatment interest for cognitive decline in neuro-oncology.Neuro-oncology practice · 2025Article
- Prevalence and Independent Risk Factors of Anxiety and Depression Symptoms in Glioma Patients: A Cross-Sectional Analysis.Psychiatry and clinical psychopharmacology · 2025Article
- The impact of financial toxicity on quality of life for survivors of primary brain tumour.Journal of cancer survivorship : research and practice · 2025Article
- Individual Work Attitudes and Work Ability.European journal of investigation in health, psychology and education · 2025Article
- Neuropsychological Evaluation for Oncology.Neurologic clinics · 2024Review
- The relationship between social determinants of health and neurocognitive and mood-related symptoms in the primary brain tumor population: A systematic review.Neuro-oncology practice · 2024Review
- Non-pharmacological fatigue interventions for patients with a primary brain tumour: a scoping review protocol.BMJ open · 2023Article
- Patient and caregiver return to work after a primary brain tumor.Neuro-oncology practice · 2023Article
- Experiences of work for people living with a grade 2/3 oligodendroglioma: a qualitative analysis within the Ways Ahead study.BMJ open · 2023Article
- Cancer survivors and adverse work outcomes: associated factors and supportive interventions.British medical bulletin · 2023Review
- Sleep disturbance in adults with untreated primary brain tumors: prevalence and impact on quality of life.Sleep and biological rhythms · 2023Article
- Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis.Cancers · 2023Review
- Surveillance of long-term complications after treatment of adult brain tumor survivors-review and evidence-based recommendations.Neuro-oncology practice · 2022Review
- Prevalence of sleep disturbances and their effects on quality of life in adults with untreated pituitary tumor and meningioma.Journal of neuro-oncology · 2021Article
- The Effect of Changes in Employment on Health of Work-Related Injured Workers: A Longitudinal Perspectives.Healthcare (Basel, Switzerland) · 2021Article
- A randomized controlled trial of a telehealth group cognitive intervention (LaTCH-BRAINS) to improve cognition after primary brain tumor diagnosis.Neuro-oncology advancesArticle
- Risk factors, predictive models, and general work ability trajectory in patients with glioma.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors (BT) are between the eight most common cancers among persons aged 40 years, with an average survival time of 10 years for patients affected by non-malignant brain tumor. Some patients continue to work, reporting difficulties in work-related activities, or even job loss. The purpose of the present study was to review the existing information about the ability people with BT to return to work and to identify factors associated with job loss. We performed a systematic review on SCOPUS and EMBASE for peer-reviewed papers that reported studies assessing work ability in patients with BT that were published in the period from January 2010 to January 2020. Out of 800 identified records, 7 articles were selected for analysis, in which 1,507 participants with BT were enrolled overall. Three main themes emerged: the impact of neuropsychological functioning on work productivity, the change of employment status for long-term survivors and issues related to return to work processes. Based on the results of selected studies, it can be concluded that the impact of BT on workforce participation is determined by depressive symptoms and cognitive deficits, as well as by high short-term mortality but also on environmental barriers. Vocational Rehabilitation programs should be implemented to help patients wishing to return to or maintain their current work, as much as possible.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.